1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid

1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid Struktur
346644-26-6
CAS-Nr.
346644-26-6
Englisch Name:
1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid
Synonyma:
ASISCHEM V63613;1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid;1-[4-(Dimethylamino)phenyl]-5-oxo-3-pyrrolidinecarboxylic acid;3-Pyrrolidinecarboxylic acid, 1-[4-(dimethylamino)phenyl]-5-oxo-
CBNumber:
CB2155083
Summenformel:
C13H16N2O3
Molgewicht:
248.28
MOL-Datei:
346644-26-6.mol

1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid Eigenschaften

storage temp. 
2-8°C

Sicherheit

HazardClass  IRRITANT

1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Yancheng KangdiSen Pharmaceutical Co., Ltd. 13812573443;18052965989
tongbenwan22@163.com China 1975 55
BePharm Ltd 400-685-9117
market@bepharm.com China 15081 60
Shanghai Pingguo Pharmaceutical Co., Ltd. 021-20432229
2412110556@qq.com China 6016 55
Aikon International Limited 025-66061636 19370895928
qqyang@aikonchem.com China 15810 58
Nextpeptide Inc +86-0571-81612335 +8613336028439
sales@nextpeptide.com China 19904 58
Zhuhai Aobokai Biomedical Technology Co., Ltd. 400-0628126
sales-team@aobchem.com.cn China 49985 58
Coresyn Pharmatech Co., Ltd. +86-571-86626709 +86-18157142896
cbc@coresyn.com China 9976 58

  • ASISCHEM V63613
  • 3-Pyrrolidinecarboxylic acid, 1-[4-(dimethylamino)phenyl]-5-oxo-
  • 1-[4-(Dimethylamino)phenyl]-5-oxo-3-pyrrolidinecarboxylic acid
  • 1-(4-Dimethylamino-phenyl)-5-oxo-pyrrolidine-3-carboxylic acid
  • 346644-26-6
Copyright 2019 © ChemicalBook. All rights reserved